Interferon β improves the efficacy of low dose cisplatin by inhibiting NF-κB/p-Akt signaling on HeLa cells.


The purpose of this study was to evaluate the anticancer efficacy of interferon β in combination with low dose of cisplatin on human cervical cancer progression, as well as its principal action mechanism. The combination treatment synergistically potentiated the effect of interferon β on cell growth inhibition and DNA damage on HeLa cells by repressing NF… (More)
DOI: 10.1016/j.biopha.2016.04.058


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics